GlassScriptPhysician profile
Nitin Sharma
NPI 1568753846
$3,320.02
in general payments reported to CMS, 2019-2025
27 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $91.89 · 2021: $667 · 2022: $509 · 2023: $192 · 2024: $106 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $621.23 | 2019-2024 | Xtandi |
| Janssen Biotech, INC. | $393.99 | 2019-2023 | Erleada |
| Procept Biorobotics Corporation | $285.86 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $263.84 | 2025 | Adstiladrin |
| Boston Scientific Corporation | $249.89 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $231.38 | 2019-2023 | |
| Neotract INC. | $206.25 | 2019 | |
| Coloplast Corp | $149.80 | 2025 | |
| Antares Pharma, INC. | $149.43 | 2021-2022 | |
| Olympus America INC. | $106.55 | 2022-2024 | Soltive, Shockpulse |
| Intuitive Surgical, INC. | $83.13 | 2019 | |
| Blue Earth Diagnostics | $82.09 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $77.07 | 2021-2024 | Prolaris |
| Sumitomo Pharma America, INC. | $73.73 | 2023 | Gemtesa |
| Urovant Sciences INC | $52.53 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $47.21 | 2019 | |
| Teleflex LLC | $45.19 | 2019-2021 | |
| Smith+Nephew, INC. | $44.38 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $28.20 | 2019 | |
| Angiodynamics, INC. | $18.25 | 2024 | Nanoknife |
| Convatec INC. | $17.20 | 2020 | |
| Abbvie INC. | $16.88 | 2022 | |
| Endo USA, INC. | $16.02 | 2025 | Xiaflex |
| Myovant Sciences INC. | $16.01 | 2022 | |
| Medtronic, INC. | $15.25 | 2022 | |
| Laborie Medical Technologies Corp. | $15.14 | 2025 | |
| Axonics, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.